Hair loss can be a big concern for many cancer patients undergoing chemotherapy, and according to a recent review of the literature published on the Clinical Journal of Oncology Nursing, «scalp cooling efficacy is dependent [more]
Rates of alcohol-related digestive cancers are expected to increase very rapidly in Europe, according to an alarming new report issued by United European Gastroenterology (UEG) that calls for a new strategic, political and clinical effort: «It [more]
Cancer control measures that have contributed to increase life expectancy in rich populations have yet to be seen in poorer populations, according to a study just published on The BMJ by a group led by [more]
Gaborone – Botswana’s cancer conscious cyclists – Team Chainring have embarked on a 1000 kilometres ‘Ride for Pink’ to create awareness and raise funds for the Cancer Association of Botswana (CAB). The cyclists’ 1000 kilometres [more]
Thousands of cancer patients in Kenya die prematurely due to lack of treatment. In a country where health insurance is a preserve of the wealthy, most patients are forced to sell their cows or land [more]
“The Big Four of the Millennium” was recently announced at the 61st Congress of the German Society of Gynaecology and Obstetrics. This honor identifies four individuals, whose life’s work created the standards of women’s health [more]
“The first time I felt a little awkward because I had never seen a breast with mastectomy and it was not an easy case. This woman had undergone many surgeries in her effort to make [more]
Pembrolizumab is the first drug approved by the U.S. Food and Drug Administration for use based on a biomarker (a specific genetic feature) rather than the location in the body where the tumor originated. The drug is indicated [more]
According to an analysis just published on American Cancer Society’s CA: A Cancer Journal for Clinicians, rare cancers account for almost a fifth of all new diagnoses, and up to over two thirds of all new diagnoses [more]
An ESO task force met to discuss the potential for “biosimilar” medical products in oncology, analyzing facts and debunking some myths. Some of the most used biologic drugs in oncology are going off patent in [more]
Countries struggling to broaden access to expensive new cancer drugs are being strongly warned to put cost-effectiveness first and not give in to political pressure. A team of researchers studied the impact of the NHS [more]
Rare cancers were among the topics discussed last month at the 3rd conference on European Reference Networks held in Vilnius, in Lithuania, where Dr Paolo Casali, from the Milan’s Istituto Nazionale dei Tumori illustrated the goals of the Joint [more]
When it comes to breast cancer screening with mammography, are women receiving a coherent message about the best age to start and to stop, and about frequency? A survey examined the situation in the United [more]